Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP991821.RAT04N6NWlS_vRJ5JE28jBTQ1AreJZSfKbGbpL8cv8hHU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP991821.RAT04N6NWlS_vRJ5JE28jBTQ1AreJZSfKbGbpL8cv8hHU130_assertion type Assertion NP991821.RAT04N6NWlS_vRJ5JE28jBTQ1AreJZSfKbGbpL8cv8hHU130_head.
- NP991821.RAT04N6NWlS_vRJ5JE28jBTQ1AreJZSfKbGbpL8cv8hHU130_assertion description "[The steps in this validation process are i) to demonstrate that a tumor antigen is over-expressed at a reasonable frequency in primary tumors and in metastases; ii) to demonstrate the immunogenicity of a tumor antigen in an appropriate animal model; iii) to demonstrate its immunogenicity and safety in humans.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP991821.RAT04N6NWlS_vRJ5JE28jBTQ1AreJZSfKbGbpL8cv8hHU130_provenance.
- NP991821.RAT04N6NWlS_vRJ5JE28jBTQ1AreJZSfKbGbpL8cv8hHU130_assertion evidence source_evidence_literature NP991821.RAT04N6NWlS_vRJ5JE28jBTQ1AreJZSfKbGbpL8cv8hHU130_provenance.
- NP991821.RAT04N6NWlS_vRJ5JE28jBTQ1AreJZSfKbGbpL8cv8hHU130_assertion SIO_000772 11815284 NP991821.RAT04N6NWlS_vRJ5JE28jBTQ1AreJZSfKbGbpL8cv8hHU130_provenance.
- NP991821.RAT04N6NWlS_vRJ5JE28jBTQ1AreJZSfKbGbpL8cv8hHU130_assertion wasDerivedFrom befree-20150227 NP991821.RAT04N6NWlS_vRJ5JE28jBTQ1AreJZSfKbGbpL8cv8hHU130_provenance.
- NP991821.RAT04N6NWlS_vRJ5JE28jBTQ1AreJZSfKbGbpL8cv8hHU130_assertion wasGeneratedBy ECO_0000203 NP991821.RAT04N6NWlS_vRJ5JE28jBTQ1AreJZSfKbGbpL8cv8hHU130_provenance.